← FDA DRUG APPROVALS

FDA ANDA · ANDA091656

OFLOXACIN

Sponsor: CADILA PHARMS LTD

APPLICATION
ANDA091656
TYPE
ANDA
ORIGINAL APPROVAL
2014-09-18
LATEST ACTION
2019-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

OFLOXACINPrescription
OFLOXACIN 300MG · TABLET · ORAL
OFLOXACINPrescription
OFLOXACIN 400MG · TABLET · ORAL
OFLOXACINPrescription
OFLOXACIN 200MG · TABLET · ORAL

Approval history

2019-10-16Labeling · Supplement 5 · standardAP
2018-10-18Labeling · Supplement 4 · standardAP
2016-07-26Labeling · Supplement 2 · standardAP
2014-09-18Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →